OBJECTIVES: The increasing number of surviving pediatric organ transplant r
ecipients has resulted in a new clinical controversy surrounding the signif
icance of adenotonsillar hypertrophy. The objective of this study is to eva
luate adenotonsillar specimens, understand characteristic histopathology, a
nd to examine the frequency and significance of this finding in this popula
tion.
METHODS., Twenty-one cases of pediatric transplant recipients with adenoida
l and/or tonsillar hypertrophy were reviewed retrospectively in a tertiary-
care setting. Particular attention was given to the histopathology of their
surgical specimens, including any evidence of posttransplantation lymphopr
oliferative disorders (PTLD).
RESULTS: Using morphologic, immunohistochemical, and molecular genetic anal
yses, 15 (71%) of 21 patients were noted to have Epstein-Barr virus (EBV)-r
elated lymphoid hyperplasia, including I case (4.7%) of PTLD. Six (29%) of
21 had evidence of reactive follicular hyperplasia not related to EBV. B-ce
ll and T-cell markers were nearly uniformly positive when tested for, excep
t in the single patient with PTLD, who exhibited polymorphic, polyclonal B-
cell morphology. Kappa and lambda light-chain clonality markers were positi
ve in 11 (92%) of 12 patients.
CONCLUSIONS. EBV-related lymphoid hyperplasia is frequently associated with
adenotonsillar hypertrophy in pediatric organ transplant patients (71% of
our cases); 92% of those cases tested exhibit polyclonal B-cell populations
. PTLD, an important cause of morbidity and mortality in this population, r
epresented approximately 5% of our cases. The remainder of cases represent
follicular hyperplasia unrelated to EBV or lymphoproliferative abnormalitie
s. Characteristic histopathologic findings are presented.